Predict your next investment

HEALTHCARE | Biotechnology
octaneco.com

See what CB Insights has to offer

Founded Year

2007

Stage

Corporate Majority | Acquired

About Octane Biotech

Octane Biotech is a medical technology company with bioreactors, bioprocesses and biomaterials for regenerative medicine.

Octane Biotech Headquarter Location

369 Dalton Ave.

Kingston, Ontario, K7K 6Z1,

Canada

613-634-6345

Latest Octane Biotech News

Cell Expansion Market Trends and Strategies of the Frontrunners and Key Shareholders in the Industry

May 8, 2020

Transparency Market Research (TMR) anticipates that the  cell expansion market  features fragmented vendor landscape owing to a large number of key players operating in the market. Takara Bio, Inc., GE Healthcare, Corning Incorporated, Terumo Corporation, Lonza Group, Octane Biotech, Inc., Danaher Corporation (Pall Corporation), PeproTech, Inc., Eppendorf AG, Becton, Dickinson and Company, Merck Millipore (Merck KGaA), Cell Signaling Technology, Inc., STEMCELL Technologies, Bio-Techne (R&D Systems), are some of the key players in the global cell expansion market. According to TMR, the cell expansion market is likely to expand by exhibiting a striking CAGR of 14.70% during the forecast period from 2016 to 2024. The market initially had gained a revenue worth US$7.7 bn in 2015, which is further expected to increase up to US$26 bn by 2024. The worldwide cell expansion market is increasing broad development fundamentally because of boundless predominance of constant ailments, which further expanding the requirement for utilization of cell expansion-based procedures. The inclination for regenerative prescriptions is likewise quick rising, which is enormously expected to move the worldwide cell expansion market’s development sooner rather than later. As more current cell-based treatments are presented, the quantity of patients who need to use the medicines increments, therefore making the market increase broad development. Finally, an ascent in biopharmaceuticals is another factor, which is probably going to foreshadow the worldwide cell expansion market to extend generously during the up and coming years. Absence of Skilled Workforce in Underdeveloped Regions Dampens Growth Surprising expense of cell expansion tasks could demoralize those having less extra cash to not decide on medicines that consolidate cell expansion-based procedures, along these lines limiting the market. This could very happen in a few economies for the most part situated in creating and immature districts of Asia Pacific and Latin America. Absence of talented workforce and cutting edge instrumentation in these locales is likewise known to generously confine the worldwide cell expansion market. By the by, a rising mindfulness about the presence of cell-expansion procedures is expanding premium levels appeared by players to develop in the market. This mindfulness can eventually contribute towards early analysis of a few endless illnesses, subsequently counterbalancing the restrictions during the up and coming years. This information is encompassed in the report by TMR, titled, “Cell Expansion Market (Cell Type – Human Stem Cells, Human Differentiated Cells, and Animal Cells; Product – Instruments, Consumables, and Disposables; End User – Hospitals, CMO & CRO, Biotechnology & Pharmaceutical Companies, and Academic & Research Institutes) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Octane Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Octane Biotech is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Octane Biotech Patents

Octane Biotech has filed 10 patents.

The 3 most popular patent topics include:

  • Biological engineering
  • Biotechnology
  • Transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/14/2020

11/24/2020

Transcription factors, Biotechnology, Cell biology, Stem cells, Biological engineering

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/14/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/24/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Biotechnology, Cell biology, Stem cells, Biological engineering

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.